Detecting Heart Attacks Faster: Two USB Studies Published in *The Lancet*
Researchers at the University Hospital of Basel (USB) have published two important studies on the diagnosis of heart attacks in the journal *The Lancet*. The findings provide new insights into how heart attacks can be reliably and as quickly as possible identified in emergency departments.
2026-11-16, 15:00
“We were able to show that a heart attack can often be reliably ruled out or confirmed within a short period of time,” says Prof. Dr. Christian Müller, director of the Cardiovascular Research Institute Basel (CRIB). “This gives doctors greater confidence when making important decisions and provides patients with clarity more quickly.”
The World’s Largest Study on This Topic
The focus is on the PRESC1SE-MI study. With over 67,000 patients from ten countries, it is the world’s largest study on heart attack diagnostics. A second publication compiles data from a total of more than 110,000 patients across international studies.
Both studies were conducted under the leadership of the Cardiovascular Research Institute Basel (CRIB) and published in *The Lancet* in 2026.
New Insights for Emergency Medicine
When a heart attack is suspected, a blood test is performed in addition to a clinical examination and an ECG. This test measures the protein troponin, which enters the bloodstream when the heart muscle is damaged.
The researchers investigated whether a second blood sample taken after just one hour is as reliable as the previously common three-hour follow-up test.
The studies show that a second blood sample taken after just one hour can be just as reliable as the three-hour test that has been commonly used to date. This can shorten the time required to reach a definitive diagnosis.
Research from Basel with International Impact
The early detection of heart attacks has been a key focus of cardiovascular research at the University Hospital Basel for many years. Several procedures that are now internationally established were co-developed and scientifically investigated in Basel.
“These publications show that research from Basel can provide important impetus for emergency medicine worldwide,” says Prof. Dr. Felix Mahfoud, Chief of Cardiology and Co-Director of the University Heart Center Basel. “Our goal is to make research findings available for patient care as quickly as possible.”
About the Studies
The PRESC1SE-MI study included 67,624 patients from 19 hospitals in 10 countries and is the world’s largest study on heart attack diagnostics. A second publication pooled data from a total of 110,933 patients from 14 countries. Both studies were published in 2026 in The Lancet.
Prof. Christian Müller, Chief Physician of Clinical Research and Director of the Cardiovascular Research Institute Basel (CRIB)
About the University Hospital of Basel
The University Hospital of Basel is the backbone of healthcare in northwestern Switzerland. It provides the best medical care for everyone and combines this with research, education, and continuing professional development. Approximately 10,000 employees cover the entire spectrum of care—from primary care to highly specialized medicine—around the clock. As a university hospital, the USB develops new medical applications through research and makes them accessible to patients.
Media Information Office